Search results
Results from the WOW.Com Content Network
Atezolizumab, sold under the brand name Tecentriq among others, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), hepatocellular carcinoma and alveolar soft part sarcoma, [9] [11] but discontinued for use in triple-negative breast cancer (TNBC). [12]
The subcutaneous injection of atezolizumab and hyaluronidase was evaluated in IMscin001 (NCT03735121), an open-label, multi-center, international, randomized trial in adults with locally advanced or metastatic non-small cell lung cancer who were not previously exposed to cancer immunotherapy and who had disease progression following treatment with platinum-based chemotherapy. [2]
The study enrolled 34 patients, 28 of which underwent surgery to resect the PDAC. 19 of the patients who had undergone surgery then received atezolizumab, an immune checkpoint inhibitor. 16 of the patients on atezolizumab then received autogene cevumeran. 1 patient was considered to have insufficiently many neoantigens to manufacture the vaccine.
Ongoing — COVID-19 pandemic in Kosovo 13 March – The first two cases of COVID-19 in the country were confirmed, a 77-year-old man from Vitina and an Italian woman in her early 20s, who worked in Klina with Caritas Kosova.
On 30 September 2021, the EU had announced they brokered a temporary deal between Serbia and Kosovo, halting the issue for six months. [43] In July 2022, the Kosovan government announced that Serbian citizens who enter Kosovo will receive entry and exit documents, sparking barricades by local Serbs in Kosovo.
This page was last edited on 19 January 2025, at 06:56 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
As of 4 September 2020, Kosovo's independence is currently recognized by 104 UN member states. [ 5 ] [ 9 ] In 2013, the Serbian government announced it was dissolving the Serb minority assemblies it had created in northern Kosovo, in order to allow the integration of the Kosovo Serb minority into the general population of Kosovo.
It all began by a 2-hour programme per day, but now it broadcasts 24/7. KOHA is a leading media house in Kosovo. KOHA is a leading media house in Kosovo. With the creation of the ORA Reformist Party in 2006, Veton Surroi transferred his control of KTV and the Koha Group to his sister Flaka Surroi .